GL検索 v0.1.0
画像は 83 ページを描画したものです
page 83

p.83 抽出テキスト

Kusumoto et al 2018 Bradycardia Clinical Practice Guidelines

August 20, 2019 Circulation. 2019;140:e382–e482. DOI: 10.1161/CIR.0000000000000628 e464

CLINICAL STATEMENTS AND GUIDELINES S5.4.2-2.	 Klein I, Danzi S. Thyroid disease and the heart. Circulation.

2007;116:1725–35. S5.4.2-3.	 Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–9. S5.4.2-4.	 Ahmad S. Hypothyroidism-induced bradycardia. J Fam Pract. 1995;41:432–3. S5.4.2-5.	 Schoenmakers N, de Graaff WE, Peters RH. Hypothyroidism as the cause of atrioventricular block in an elderly patient. Neth Heart J. 2008;16:57–9. S5.4.2-6.	 Crowley WF Jr, Ridgway EC, Bough EW, et al. Noninvasive evalu-

ation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med. 1977;296:1–6.

5.4.3 Additional Testing of Bradycardia Attributable to SND

S5.4.3-1.	 Alboni P, Filippi L, Pirani R, et al. Reproducibility of electrophysiological parameters of sinus node following autonomic blockade. Int J Cardiol. 1983;4:431–42. S5.4.3-2.	 Bergfeldt L, Vallin H, Rosenqvist M, et al. Sinus node recovery time assessment revisited: role of pharmacologic blockade of the autonomic nervous system. J Cardiovasc Electrophysiol. 1996;7:95–101. S5.4.3-3.	 Narula OS, Shantha N, Vasquez M, et al. A new method for measurement of sinoatrial conduction time. Circulation. 1978;58:706–14. S5.4.3-4.	 Reiffel JA, Kuehnert MJ. Electrophysiological testing of sinus node function: diagnostic and prognostic application-including updated information from sinus node electrograms. Pacing Clin Electrophysiol. 1994;17:349–65. S5.4.3-5.	 Strauss HC, Saroff AL, Bigger JT Jr, et al. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Presentation of data and critical review of the literature. Circulation. 1973;47:86–93. S5.4.3-6.	 Denniss AR, Ross DL, Richards DA, et al. Electrophysiologic studies in patients with unexplained syncope. Int J Cardiol. 1992;35:211–7. S5.4.3-7.	 de Marneffe M, Jacobs P, Englert M. Reproducibility of electrophysiologic parameters of extrinsic sinus node function in patients with and without sick sinus syndrome. Pacing Clin Electrophysiol. 1986;9:482–9. S5.4.3-8.	 Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e60–122. S5.4.3-9.	 Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/ HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e272–391. S5.4.3-10.	Gomes JA, Kang PS, El-Sherif N. The sinus node electrogram in

patients with and without sick sinus syndrome: techniques and correlation between directly measured and indirectly estimated sinoatrial conduction time. Circulation. 1982;66:864–73. 5.4.4. Permanent Pacing for Chronic Therapy/Management of Bradycardia Attributable to SND S5.4.4-1.	 Sharma AD, Rizo-Patron C, Hallstrom AP, et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm. 2005;2:830–4. S5.4.4-2.	 Sweeney MO, Prinzen FW. A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol. 2006;47:282–8. S5.4.4-3.	 Alboni P, Menozzi C, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation. 1997;96:260–6. S5.4.4-4.	 Saito D, Matsubara K, Yamanari H, et al. Effects of oral theophylline on sick sinus syndrome. J Am Coll Cardiol. 1993;21:1199–204. S5.4.4-5.	 Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused

update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016;134:e282–93. S5.4.4-6.	 Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline

for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–327. S5.4.4-7.	 O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–425. S5.4.4-8.	 Jackson LR 2nd, Rathakrishnan B, Campbell K, et al. Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? Pacing Clin Electrophysiol. 2017;40:442–50. S5.4.4-9.	 Menozzi C, Brignole M, Alboni P, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome. Am J Cardiol. 1998;82: 1205–9. S5.4.4-10.	 Alt E, Volker R, Wirtzfeld A, et al. Survival and follow-up after pacemaker implantation: a comparison of patients with sick sinus syndrome, complete heart block, and atrial fibrillation. Pacing Clin Electrophysiol. 1985;8:849–55. S5.4.4-11.	 Hocini M, Sanders P, Deisenhofer I, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 2003;108:1172–5. S5.4.4-12.	 Chen YW, Bai R, Lin T, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37:403–11. S5.4.4-13.	 Lamas GA, Knight JD, Sweeney MO, et al. Impact of rate-modulated pacing on quality of life and exercise capacity–evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm. 2007;4:1125–32. S5.4.4-14.	 Maity AK, Ghosh SP, Dasbiswas A, et al. Haemodynamic advantage with single chamber rate responsive pacemakers over dual chamber pacemakers during exercise in chronotropic incompetence. Indian Heart J. 1992;44:231–4. S5.4.4-15.	 Santini M, Ricci R, Puglisi A, et al. Long-term haemodynamic and

antiarrhythmic benefits of DDIR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence. G Ital Cardiol. 1997;27:892–900. 5.4.4.1. Permanent Pacing Techniques and Methods for Chronic Therapy/Management of Bradycardia Attributable to SND S5.4.4.1-1.	 Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350:1210–6. S5.4.4.1-2.	 Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000;342:1385–91. S5.4.4.1-3.	 Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346:1854–62. S5.4.4.1-4.	 Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med. 1998;338:1097–104. S5.4.4.1-5.	 Brandt NH, Kirkfeldt RE, Nielsen JC, et al. Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial. Europace. 2017;19:1981–7. S5.4.4.1-6.	 Sweeney MO, Bank AJ, Nsah E, et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007;357:1000–8. S5.4.4.1-7.	 Gillis AM, Russo AM, Ellenbogen KA, et al. HRS/ACCF expert consensus statement on pacemaker device and mode selection. J Am Coll Cardiol. 2012;60:682–703. S5.4.4.1-8.	 Dretzke J, Toff WD, Lip GY, et al. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. Cochrane Database Syst Rev. 2004: CD003710. S5.4.4.1-9.	 Andersen HR, Nielsen JC, Thomsen PE, et al. Atrioventricular con-

duction during long-term follow-up of patients with sick sinus syndrome. Circulation. 1998;98:1315–21.

Downloaded from http://ahajournals.org by on October 7, 2026